Drug Profile
P 2745
Alternative Names: P2745Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Piramal Life Sciences
- Developer Piramal Phytocare
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Haematological malignancies
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Haematological-malignancies(Second-line therapy or greater) in India (PO, Tablet)
- 23 May 2013 Piramal Life Sciences terminates phase I trial in Haematological malignancies in India
- 15 Jul 2011 Phase-I clinical trials in Haematological malignancies in India (PO)